Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial
Abstract Background The clinical manifestation of COVID-19 is associated with infection and inflammation of the lungs, but there is evidence to suggest that COVID-19 may also affect the structure and function of the cardiovascular system. At present, it is not fully understood to what extent COVID-1...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-05-01
|
| Series: | Trials |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13063-023-07360-7 |
| _version_ | 1827947958439510016 |
|---|---|
| author | Mushidur Rahman Sophie L. Russell Nduka C. Okwose Olivia M. A. Hood Amy E. Harwood Gordon McGregor Stuart M. Raleigh Hardip Sandhu Laura C. Roden Helen Maddock Prithwish Banerjee Djordje G. Jakovljevic |
| author_facet | Mushidur Rahman Sophie L. Russell Nduka C. Okwose Olivia M. A. Hood Amy E. Harwood Gordon McGregor Stuart M. Raleigh Hardip Sandhu Laura C. Roden Helen Maddock Prithwish Banerjee Djordje G. Jakovljevic |
| author_sort | Mushidur Rahman |
| collection | DOAJ |
| description | Abstract Background The clinical manifestation of COVID-19 is associated with infection and inflammation of the lungs, but there is evidence to suggest that COVID-19 may also affect the structure and function of the cardiovascular system. At present, it is not fully understood to what extent COVID-19 impacts cardiovascular function in the short- and long-term following infection. The aim of the present study is twofold: (i) to define the effect of COVID-19 on cardiovascular function (i.e. arterial stiffness, cardiac systolic and diastolic function) in otherwise healthy individuals and (ii) to evaluate the effect of a home-based physical activity intervention on cardiovascular function in people with a history of COVID-19. Methods This prospective, single-centre, observational study will recruit 120 COVID-19-vaccinated adult participants aged between 50 and 85 years, i.e. 80 with a history of COVID-19 and 40 healthy controls without a history of COVID-19. All participants will undergo baseline assessments including 12-lead electrocardiography, heart rate variability, arterial stiffness, rest and stress echocardiography with speckle tracking imaging, spirometry, maximal cardiopulmonary exercise testing, 7-day physical activity and sleep measures and quality of life questionnaires. Blood samples will be collected to assess the microRNA expression profiles, cardiac and inflammatory biomarkers, i.e. cardiac troponin T; N-terminal pro B-type natriuretic peptide; tumour necrosis factor alpha; interleukins 1, 6 and 10; C-reactive protein; d-dimer; and vascular endothelial growth factors. Following baseline assessments, COVID-19 participants will be randomised 1:1 into a 12-week home-based physical activity intervention aiming to increase their daily number of steps by 2000 from baseline. The primary outcome is change in left ventricular global longitudinal strain. Secondary outcomes are arterial stiffness, systolic and diastolic function of the heart, functional capacity, lung function, sleep measures, quality of life and well-being (depression, anxiety, stress and sleep efficiency). Discussion The study will provide insights into the cardiovascular implications of COVID-19 and their malleability with a home-based physical activity intervention. Trial registration ClinicalTrials.gov NCT05492552. Registered on 7 April 2022. |
| first_indexed | 2024-04-09T12:46:54Z |
| format | Article |
| id | doaj.art-071c874985204d76b68cd646914a88f7 |
| institution | Directory Open Access Journal |
| issn | 1745-6215 |
| language | English |
| last_indexed | 2024-04-09T12:46:54Z |
| publishDate | 2023-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Trials |
| spelling | doaj.art-071c874985204d76b68cd646914a88f72023-05-14T11:26:49ZengBMCTrials1745-62152023-05-012411910.1186/s13063-023-07360-7Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trialMushidur Rahman0Sophie L. Russell1Nduka C. Okwose2Olivia M. A. Hood3Amy E. Harwood4Gordon McGregor5Stuart M. Raleigh6Hardip Sandhu7Laura C. Roden8Helen Maddock9Prithwish Banerjee10Djordje G. Jakovljevic11Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversitySchool of Biosciences, College of Biomedical and Life Sciences, Cardiff UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityResearch Centre for Health and Life Sciences, Institute for Health and Wellbeing, Faculty of Health and Life Sciences, Coventry UniversityAbstract Background The clinical manifestation of COVID-19 is associated with infection and inflammation of the lungs, but there is evidence to suggest that COVID-19 may also affect the structure and function of the cardiovascular system. At present, it is not fully understood to what extent COVID-19 impacts cardiovascular function in the short- and long-term following infection. The aim of the present study is twofold: (i) to define the effect of COVID-19 on cardiovascular function (i.e. arterial stiffness, cardiac systolic and diastolic function) in otherwise healthy individuals and (ii) to evaluate the effect of a home-based physical activity intervention on cardiovascular function in people with a history of COVID-19. Methods This prospective, single-centre, observational study will recruit 120 COVID-19-vaccinated adult participants aged between 50 and 85 years, i.e. 80 with a history of COVID-19 and 40 healthy controls without a history of COVID-19. All participants will undergo baseline assessments including 12-lead electrocardiography, heart rate variability, arterial stiffness, rest and stress echocardiography with speckle tracking imaging, spirometry, maximal cardiopulmonary exercise testing, 7-day physical activity and sleep measures and quality of life questionnaires. Blood samples will be collected to assess the microRNA expression profiles, cardiac and inflammatory biomarkers, i.e. cardiac troponin T; N-terminal pro B-type natriuretic peptide; tumour necrosis factor alpha; interleukins 1, 6 and 10; C-reactive protein; d-dimer; and vascular endothelial growth factors. Following baseline assessments, COVID-19 participants will be randomised 1:1 into a 12-week home-based physical activity intervention aiming to increase their daily number of steps by 2000 from baseline. The primary outcome is change in left ventricular global longitudinal strain. Secondary outcomes are arterial stiffness, systolic and diastolic function of the heart, functional capacity, lung function, sleep measures, quality of life and well-being (depression, anxiety, stress and sleep efficiency). Discussion The study will provide insights into the cardiovascular implications of COVID-19 and their malleability with a home-based physical activity intervention. Trial registration ClinicalTrials.gov NCT05492552. Registered on 7 April 2022.https://doi.org/10.1186/s13063-023-07360-7COVID-19CoronavirusCardiovascular systemRandomised controlled trialEchocardiographyArterial stiffness |
| spellingShingle | Mushidur Rahman Sophie L. Russell Nduka C. Okwose Olivia M. A. Hood Amy E. Harwood Gordon McGregor Stuart M. Raleigh Hardip Sandhu Laura C. Roden Helen Maddock Prithwish Banerjee Djordje G. Jakovljevic Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial Trials COVID-19 Coronavirus Cardiovascular system Randomised controlled trial Echocardiography Arterial stiffness |
| title | Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial |
| title_full | Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial |
| title_fullStr | Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial |
| title_full_unstemmed | Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial |
| title_short | Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial |
| title_sort | cardiovascular implications and physical activity in middle aged and older adults with a history of covid 19 cv covid a protocol for a randomised controlled trial |
| topic | COVID-19 Coronavirus Cardiovascular system Randomised controlled trial Echocardiography Arterial stiffness |
| url | https://doi.org/10.1186/s13063-023-07360-7 |
| work_keys_str_mv | AT mushidurrahman cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT sophielrussell cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT ndukacokwose cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT oliviamahood cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT amyeharwood cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT gordonmcgregor cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT stuartmraleigh cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT hardipsandhu cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT lauracroden cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT helenmaddock cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT prithwishbanerjee cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial AT djordjegjakovljevic cardiovascularimplicationsandphysicalactivityinmiddleagedandolderadultswithahistoryofcovid19cvcovidaprotocolforarandomisedcontrolledtrial |